Please assess the completion status of the following clinical trial:

Trial Title: Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Scheduled for catheterization/coronary angiography~2. Undergoing diagnostic coronary angiography to define the coronary anatomy with the intent for revascularization (ad-hoc PCI) or planned PCI to define the coronary anatomy with the intent for revascularization due to one of the following:~   1. exertional or rest chest pain (or angina equivalent)~  2. abnormal Exercise Stress Test~  3. abnormal nuclear tests~  4. abnormal pharmacologic or stress echocardiogram, or pharmacologic MRI~  5. abnormal EKGs~  6. abnormal Calcium scores~  7. abnormal coronary CT angiogram~3. Ability and willingness to consent and Authorization for use of PHI~Exclusion Criteria:~1. ACS (STEMI, UA/NSTEMI)~2. Positive Troponin I per local laboratory standards~3. Known EF\<30%~4. GFR\<50% (calculation using the IDMS-Traceable MDRD study equation~5. Dye Allergy that unable to be safely premedicated~6. Known current or history of bleeding diathesis~7. Current or anticipated treatment with warfarin, oral factor Xa inhibitor, oral direct thrombin inhibitor, LMWH, or TNK~8. Known platelet count \<100,000/mm³ or known INR \>1.5 at time of enrollment~9. Hgb \<10 g/dL and/or Hct \< 30%~10. Residence \>60 minutes from the hospital~11. Reliable caregiver not available for home post PCI recovery~12. Participation in another study that would require hospital procedures or test post PCI prior to discharge~13. Inability or unwillingness to consent for study, follow up procedures and Authorization for use of PHI~14. Physician clinical determination participant is not suitable for study participation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Same-day discharge (Type: EXPERIMENTAL): Same-day discharge following PCI

Based on this trial design, predict the completion outcome and termination type (if applicable).